End Sud, INC. DBA End Substance Use Disorder

Based in TX

🤖

AI Overview

With $270K in lobbying spend across 10 quarterly filings, End Sud, INC. DBA End Substance Use Disorder is an active lobbying client. Their lobbying covers 2 issue areas. Active from 2021 to 2022.

$270K

Total Spend

Years Active

Firms Hired

Lobbyists Deployed

Issues Lobbied

Spending Trend

View as table

Year	Lobbying Spend
2021	$200K
2022	$70K

Issues Lobbied

Alcohol & Drug Abuse Medicare/Medicaid

Lobbying Firms

End Sud, INC. DBA End Substance Use Disorder

Lobbyists

Erin Schanning Kristina Travis

Government Agencies Targeted

These are the government entities that End Sud, INC. DBA End Substance Use Disorder disclosed contacting in their lobbying filings.

Executive Office of the President (EOP)Health & Human Services, Dept of (HHS)HOUSE OF REPRESENTATIVESSENATEOffice of Natl Drug Control Policy (NDCP)Substance Abuse & Mental Health Services Administration (SAMHSA)Drug Enforcement Administration (DEA)Justice, Dept of (DOJ)

View all agency pressure data →

What They Lobby About

These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Alcohol & Drug Abuse, Medicare/Medicaid

Mainstreaming Addiction Treatment Act (H.R. 1384, S. 445) and policies to end substance use disorder.

H.R.1384, S.445, THE MAINSTREAMING ADDICTION TREATMENT ACT, ALL PROVISIONS; U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, PRACTICE GUIDELINES FOR THE ADMINISTRATION OF BUPRENORPHINE FOR TREATING OPIOI

H.R.1384, S.445, THE MAINSTREAMING ADDICTION TREATMENT ACT, ALL PROVISIONS.

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES, PRACTICE GUIDELINES FOR THE ADMINISTRATION OF BUPRENORPHINE FOR TREATING OPIO